Biora Therapeutics, Inc.
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-12/IL-23 INHIBITOR RELEASED USING AN INGESTIBLE DEVICE
Last updated:
Abstract:
This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor.
Status:
Application
Type:
Utility
Filling date:
14 Dec 2017
Issue date:
20 Aug 2020